Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, no par value
-
Total 13F shares
-
19,485,779
-
Share change
-
+52,731
-
Total reported value
-
$236,188,655
-
Price per share
-
$12.12
-
Number of holders
-
82
-
Value change
-
+$1,641,308
-
Number of buys
-
40
-
Number of sells
-
32
Institutional Holders of Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) as of Q3 2019
As of 30 Sep 2019,
Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,485,779 shares.
The largest 10 holders included
FMR LLC, Camber Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., MFN Partners Management, LP, Artal Group S.A., VANGUARD GROUP INC, UBS ASSET MANAGEMENT AMERICAS INC, Slate Path Capital LP, and EcoR1 Capital, LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.